Nkarta Therapeutics Competitors and Similar CompaniesClear all

Nkarta Therapeutics's competitors and similar companies include AsclepiX Therapeutics, Lyell, Courier Therapeutics and OncoQR ML.

	Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.	AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Courier Therapeutics Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.	OncoQR ML OncoQR ML is a biotech company that develops cancer immunotherapies.
Founding Date	Founding Date 2015	Founding Date 2011	Founding Date 2018	Founding Date 2015	Founding Date 2013
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy
Locations	Locations South San Francisco, US HQ	Locations Baltimore, US HQ Jersey City, US	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Houston, US HQ Houston, US	Locations Wien, AT HQ Irenental, AT Wien, AT
Employees	Employees 1594% decrease	Employees 7	Employees 188	Employees 1	Employees 3
Valuation ($)	Valuation ($) 240.6 m	Valuation ($) N/A	Valuation ($) 243.3 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($108.8m) (FY, 2024)	Net income N/A	Net income ($343m) (FY, 2024)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 125m	Total funding raised $ 40m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A